MPs raise concerns over vaccine supply after Pfizer shuts cold storage site

Concerns have been raised about the risk of disruption to supplies of the Pfizer coronavirus vaccine and added costs after the drugs company shut a cold storage facility in the south of England ahead of the end of the Brexit transition period next month. Britain has ordered 40 million doses of the vaccine from Pfizer and BioNTech, its German partner, which unveiled breakthrough interim results from a late-stage trial this month. Operations at a Pfizer vaccine packaging and distribution plant in Havant have been winding down before a transfer to a manufacturing site at Puurs in Belgium in October